Latest | F'cast | |
---|---|---|
Div Yield | 2.3% | 0.0% |
Div Cover | 9.6 | n/a |
Op Mrgn | 51.3% | n/a |
ROCE | 4.7% |
Latest | F'cast | |
---|---|---|
P/E | 5.9 | n/a |
PEG | n/a | n/a |
Pr/Revenue | 1.6 | n/a |
Pr/Book | 0.4 |
Latest | F'cast | |
---|---|---|
Revenue | -29.9% | n/a |
PBT | -62.4% | n/a |
EPS | -59.3% | n/a |
DPS | -44.4% | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-20 | 35.83 | 8.05 | 5.02¢ | 23.0 | n/a | -42% | n/a | 0.0% |
30-Jun-21 | 36.92 | 12.93 | 0.09¢ | 2,026.3 | n/a | -99% | n/a | 0.0% |
30-Jun-22 | 67.18 | 45.75 | 32.65¢ | 5.9 | 0.0 | +18,538% | n/a | 0.0% |
30-Jun-23 | 72.78 | 42.74 | 29.53¢ | 3.6 | n/a | -30% | 2.25¢ | 2.1% |
30-Jun-24 | 50.99 | 16.05 | 12.01¢ | 11.8 | n/a | -59% | 1.25¢ | 0.9% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Outcome of Commercial Arbitration Investment | 01-Apr-2025 | 07:00 | RNS |
Interim results for the HY ended 31 December 2024 | 18-Mar-2025 | 07:00 | RNS |
Appeal Filed in Class Action Investment | 28-Feb-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 54.40p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 120.75 |
52 Week Low | 54.40 |
Volume | 0 |
Shares Issued | 114.28m |
Market Cap | £62.17m |
RiskGrade | 218 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 03-Oct-24 | 28-Sep-23 |
Paid | 25-Oct-24 | 27-Oct-23 |
Amount | 1.25p | 2.25p |
Time | Volume / Share Price |
0 @ 0.000p |
CEO | Patrick Moloney |
CFO | David Collins |
You are here: research